Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Assets Average (2016 - 2022)

Edesa Biotech's Assets Average history spans 9 years, with the latest figure at $19.0 million for Q2 2022.

  • For Q2 2022, Assets Average fell 7.17% year-over-year to $19.0 million; the TTM value through Jun 2022 reached $19.0 million, down 7.17%, while the annual FY2021 figure was $12.7 million, 12.44% up from the prior year.
  • Assets Average for Q2 2022 was $19.0 million at Edesa Biotech, up from $16.4 million in the prior quarter.
  • Across five years, Assets Average topped out at $20.4 million in Q2 2021 and bottomed at $6.0 million in Q1 2018.
  • The 5-year median for Assets Average is $9.8 million (2020), against an average of $11.3 million.
  • The largest annual shift saw Assets Average tumbled 45.03% in 2018 before it skyrocketed 169.55% in 2021.
  • A 5-year view of Assets Average shows it stood at $7.6 million in 2018, then fell by 18.85% to $6.2 million in 2019, then surged by 70.93% to $10.5 million in 2020, then increased by 27.9% to $13.5 million in 2021, then skyrocketed by 40.93% to $19.0 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Assets Average are $19.0 million (Q2 2022), $16.4 million (Q1 2022), and $13.5 million (Q4 2021).